1175P Temozolomide alone or combined with capecitabine for the treatment of metastatic neuroendocrine neoplasia: A “Real World” data analysis

Temozolomide Progression-free survival
DOI: 10.1016/j.annonc.2020.08.1388 Publication Date: 2020-09-22T04:56:29Z